<DOC>
	<DOCNO>NCT02553824</DOCNO>
	<brief_summary>This study demonstrate efficacy Qsymia versus placebo treat bulimia nervosa binge eat disorder .</brief_summary>
	<brief_title>FDA Approved Medication Reduce Binge Eating and/or Purging</brief_title>
	<detailed_description>Bulimia nervosa ( BN ) binge eat disorder ( BED ) serious mental disorder associate adverse psychological physical consequence . Treatment option date offer limited success , leave least 50-70 % patient still symptomatic treatment . The purpose study evaluate whether phentermine-topiramate ( Qsymia ) , medication currently FDA approve treatment obesity , demonstrate efficacyâ€”compared placebo- re-purposed patient bulimia binge eat . Participants randomize one two condition : qsymia Placebo . One condition receive 3 month phentermine-topiramate , 2 week washout , 3 month placebo . The condition receive 3 month Placebo , 2 week washout , 3 month phentermine-topiramate . Participants receive total 6 month treatment 2 month follow-up medication .</detailed_description>
	<mesh_term>Binge-Eating Disorder</mesh_term>
	<mesh_term>Feeding Eating Disorders</mesh_term>
	<mesh_term>Bulimia</mesh_term>
	<mesh_term>Bulimia Nervosa</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<mesh_term>Phentermine</mesh_term>
	<criteria>Must meet Diagnostic Statistical Manual Edition 5 criterion bulimia binge eat disorder , respond prior treatment Men woman age 1860 Must least normal weight ( i.e . body mass index least 21.0 great ) If female childbearing potential , participant must initial negative pregnancy test take adequate birth control must medically stable new diagnosis ( medical , surgical , psychiatric ) within past 6 month Must live close enough within commute distance study site ( Stanford , CA ) able comply study visit , treatment plan , blood draw possible assessment ( i.e . EKG ) Any patient bipolar disease schizophrenia patient take mood stabilizer antipsychotic medication within past 3 month Any patient current past history anorexia nervosa ( i.e. , Body mass index &lt; 17.5 ) . Any patient prior ( within 30 day ) use Over The Counter ( OTC ) weightreducing agent , herbal preparation Any patient prescribed medication weight loss within past 3 month Any psychological weightloss intervention ( i.e. , Weight Watchers , Jenny Craig ) patient lose weight past month ( unless willing discontinue ) . Any patient currently therapy psychostimulant use psychostimulant within past 6 month Any patient know sensitivity phentermine topiramate Any patient change thyroid , psychiatric , blood pressure medication within past one month Any patient take potassiumwasting diuretic Any patient carbonic anhydrase inhibitor zonisamide acetazolamide , dichlorphenamide Any diabetic taking insulin insulin secretagogue Any patient liver enzymes baseline great three time upper limit normal Any patient baseline potassium le 3.0 millequivalent/Liter . Patients baseline potassium level 3.03.5 miliEquivalents/Liter encourage ingest high potassium food banana , orange , tomato juice daily study Any patient abnormal baseline thyroid test Thyroid Stimulating Hormone ( TSH ) great 1.5 time upper limit normal Any patient unwilling express uncertainty able refrain daily alcohol use ( even moderate level ) illegal drug take study medication . Any adult recent history suspect alcohol substance abuse substance dependence Any patient regularly use marijuana ( include medical marijuana ) illegal drug Any patient history addiction stimulant Any patient express current suicidal ideation Any patient history nephrolithiasis Any patient pregnant planning become pregnant study period . Any patient currently participate clinical study involve active treatment Any patient unable identify primary care physician Any patient history cardiovascular disease ( i.e . recent history Myocardial Infarction , stroke , shortness breath , chest pain ) could increase vulnerability sympathomimetic effect stimulant like drug . If clinical suspicion high , baseline EKG obtain anyone abnormal finding exclude</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>binge eat</keyword>
	<keyword>bulimia nervosa</keyword>
	<keyword>binge eat disorder</keyword>
	<keyword>eat disorder treatment</keyword>
</DOC>